By Grand Rapids Anonymous
tuesday, december 2, 2025 at 5:19:00 p.m. est
“(epoch times) Pfizer’s experimental influenza vaccine will not receive approval absent new data proving that it protects seniors against the flu, the commissioner of the food and drug administration suggested in a new interview.
“the messenger ribonucleic acid (mRNA) shot 'failed in seniors,' dr. Marty Makary, the fda commissioner, said during an appearance on nov. 29 on Fox news.
“'the trial showed zero benefit,” he said.
“'we’re not just going to rubber-stamp new products that don’t work, that fail in a clinical trial. it makes a mockery of science if we’re just going to rubber-stamp things with no data.”
[GRA: biden's fda would have approved it.]
“Pfizer’s media team did not respond to a request for comment.
“the experimental mRNA shot performed better in a trial than an already-approved vaccine from a different company among healthy people aged 18 to 64, researchers with Pfizer and other organizations said in a recent paper published by the new england journal of medicine (nejm).
“many more seniors—68.7 percent—reported adverse reactions within seven days of [sic] Pfizer vaccination compared with just 25.8 percent of recipients of the existing vaccine, the results also showed.”
--GRA
By Grand Rapids Anonymous
wednesday, december 3, 2025 at 2:10:00 a.m. est
“25% have adverse reactions.”
GRA: Acceptable (sarcasm).
--GRA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment